The CA 15-3 is as an alternative marker for KL-6 (serum Krebs von den Lungen-6) in fibrotic lung diseases which increases in pulmonary interstitial damage, fibroblast activity and progression to fibrosis of the lung15,16 and might be of great interest when studying the effects of COVID-19. Here, MUC1 is linked to COVID-19.